Confounders such as sex, age, systemic hypertension, obstructive sleep apnea, hyperlipidemia and coronary artery disease were all accounted for, as were contraindications for use of semaglutide
Semaglutide was approved by the FDA in 2017 and has been shown to lower A1c (average blood sugar over 2-3 months), according to large clinical trials
Gender-specific considerations when using BPC-157 in fertility plans include: Female: Timing with menstrual cycle impacts endometrium and implantation window
Too much at one time can cause more gastrointestinal distress than it solves, Keatley says
J Clin Microbiol 55 , 504509, (2017)
The ASA recognized this and updated their pre-procedure guidance accordingly